ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Antiretroviral Drug Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-8V6116
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Antiretroviral Drug Market Insights Forecast to 2028
BUY CHAPTERS

Global Antiretroviral Drug Market Insights, Forecast to 2030

Code: QYRE-Auto-8V6116
Report
December 2024
Pages:98
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Gilead Sciences
ViiV Healthcare
Bristol Myer Squibb
AbbVie
Boehringer Ingelheim
Johnson and Johnson
Merck
Cipla Ltd

Antiretroviral Drug Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Antiretroviral Drug Market

Antiretroviral Drug Market

Tire-derived fuel (TDF) is composed of shredded scrap tires.
Market Analysis and Insights: Global Antiretroviral Drug Market
The global Antiretroviral Drug market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Antiretroviral Drug market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Antiretroviral Drug, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Antiretroviral Drug, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Antiretroviral Drug revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Antiretroviral Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Antiretroviral Drug revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Antiretroviral Drug Market Report

Report Metric Details
Report Name Antiretroviral Drug Market
CAGR 5%
Segment by Type
Segment by Application
  • Hospital
  • Pharmaceutical Companies
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Gilead Sciences, ViiV Healthcare, Bristol-Myer Squibb, AbbVie, Boehringer-Ingelheim, Johnson and Johnson, Merck, CIPLA
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Antiretroviral Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Antiretroviral Drug companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Antiretroviral Drug revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Antiretroviral Drug Market report?

Ans: The main players in the Antiretroviral Drug Market are Gilead Sciences, ViiV Healthcare, Bristol-Myer Squibb, AbbVie, Boehringer-Ingelheim, Johnson and Johnson, Merck, CIPLA

What are the Application segmentation covered in the Antiretroviral Drug Market report?

Ans: The Applications covered in the Antiretroviral Drug Market report are Hospital, Pharmaceutical Companies, Other

What are the Type segmentation covered in the Antiretroviral Drug Market report?

Ans: The Types covered in the Antiretroviral Drug Market report are Multi-Class Drugs Combination, NRTI, NNRTI, Protease Inhibitors, Other

Recommended Reports

Antiviral Drug Markets

Infectious Disease Drugs

Therapeutics & Related

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antiretroviral Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Multi-Class Drugs Combination
1.2.3 NRTI
1.2.4 NNRTI
1.2.5 Protease Inhibitors
1.2.6 Other
1.3 Market by Application
1.3.1 Global Antiretroviral Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Pharmaceutical Companies
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antiretroviral Drug Market Perspective (2019-2030)
2.2 Global Antiretroviral Drug Growth Trends by Region
2.2.1 Antiretroviral Drug Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Antiretroviral Drug Historic Market Size by Region (2019-2024)
2.2.3 Antiretroviral Drug Forecasted Market Size by Region (2025-2030)
2.3 Antiretroviral Drug Market Dynamics
2.3.1 Antiretroviral Drug Industry Trends
2.3.2 Antiretroviral Drug Market Drivers
2.3.3 Antiretroviral Drug Market Challenges
2.3.4 Antiretroviral Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Antiretroviral Drug by Players
3.1.1 Global Antiretroviral Drug Revenue by Players (2019-2024)
3.1.2 Global Antiretroviral Drug Revenue Market Share by Players (2019-2024)
3.2 Global Antiretroviral Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Antiretroviral Drug, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Antiretroviral Drug Market Concentration Ratio
3.4.1 Global Antiretroviral Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antiretroviral Drug Revenue in 2023
3.5 Global Key Players of Antiretroviral Drug Head office and Area Served
3.6 Global Key Players of Antiretroviral Drug, Product and Application
3.7 Global Key Players of Antiretroviral Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Antiretroviral Drug Breakdown Data by Type
4.1 Global Antiretroviral Drug Historic Market Size by Type (2019-2024)
4.2 Global Antiretroviral Drug Forecasted Market Size by Type (2025-2030)
5 Antiretroviral Drug Breakdown Data by Application
5.1 Global Antiretroviral Drug Historic Market Size by Application (2019-2024)
5.2 Global Antiretroviral Drug Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Antiretroviral Drug Market Size (2019-2030)
6.2 North America Antiretroviral Drug Market Size by Type
6.2.1 North America Antiretroviral Drug Market Size by Type (2019-2024)
6.2.2 North America Antiretroviral Drug Market Size by Type (2025-2030)
6.2.3 North America Antiretroviral Drug Market Share by Type (2019-2030)
6.3 North America Antiretroviral Drug Market Size by Application
6.3.1 North America Antiretroviral Drug Market Size by Application (2019-2024)
6.3.2 North America Antiretroviral Drug Market Size by Application (2025-2030)
6.3.3 North America Antiretroviral Drug Market Share by Application (2019-2030)
6.4 North America Antiretroviral Drug Market Size by Country
6.4.1 North America Antiretroviral Drug Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Antiretroviral Drug Market Size by Country (2019-2024)
6.4.3 North America Antiretroviral Drug Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Antiretroviral Drug Market Size (2019-2030)
7.2 Europe Antiretroviral Drug Market Size by Type
7.2.1 Europe Antiretroviral Drug Market Size by Type (2019-2024)
7.2.2 Europe Antiretroviral Drug Market Size by Type (2025-2030)
7.2.3 Europe Antiretroviral Drug Market Share by Type (2019-2030)
7.3 Europe Antiretroviral Drug Market Size by Application
7.3.1 Europe Antiretroviral Drug Market Size by Application (2019-2024)
7.3.2 Europe Antiretroviral Drug Market Size by Application (2025-2030)
7.3.3 Europe Antiretroviral Drug Market Share by Application (2019-2030)
7.4 Europe Antiretroviral Drug Market Size by Country
7.4.1 Europe Antiretroviral Drug Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Antiretroviral Drug Market Size by Country (2019-2024)
7.4.3 Europe Antiretroviral Drug Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Antiretroviral Drug Market Size (2019-2030)
8.2 China Antiretroviral Drug Market Size by Type
8.2.1 China Antiretroviral Drug Market Size by Type (2019-2024)
8.2.2 China Antiretroviral Drug Market Size by Type (2025-2030)
8.2.3 China Antiretroviral Drug Market Share by Type (2019-2030)
8.3 China Antiretroviral Drug Market Size by Application
8.3.1 China Antiretroviral Drug Market Size by Application (2019-2024)
8.3.2 China Antiretroviral Drug Market Size by Application (2025-2030)
8.3.3 China Antiretroviral Drug Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Antiretroviral Drug Market Size (2019-2030)
9.2 Asia Antiretroviral Drug Market Size by Type
9.2.1 Asia Antiretroviral Drug Market Size by Type (2019-2024)
9.2.2 Asia Antiretroviral Drug Market Size by Type (2025-2030)
9.2.3 Asia Antiretroviral Drug Market Share by Type (2019-2030)
9.3 Asia Antiretroviral Drug Market Size by Application
9.3.1 Asia Antiretroviral Drug Market Size by Application (2019-2024)
9.3.2 Asia Antiretroviral Drug Market Size by Application (2025-2030)
9.3.3 Asia Antiretroviral Drug Market Share by Application (2019-2030)
9.4 Asia Antiretroviral Drug Market Size by Region
9.4.1 Asia Antiretroviral Drug Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Antiretroviral Drug Market Size by Region (2019-2024)
9.4.3 Asia Antiretroviral Drug Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Antiretroviral Drug Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Antiretroviral Drug Market Size by Type
10.2.1 Middle East, Africa, and Latin America Antiretroviral Drug Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Antiretroviral Drug Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Antiretroviral Drug Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Antiretroviral Drug Market Size by Application
10.3.1 Middle East, Africa, and Latin America Antiretroviral Drug Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Antiretroviral Drug Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Antiretroviral Drug Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Antiretroviral Drug Market Size by Country
10.4.1 Middle East, Africa, and Latin America Antiretroviral Drug Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Antiretroviral Drug Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Antiretroviral Drug Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Gilead Sciences
11.1.1 Gilead Sciences Company Details
11.1.2 Gilead Sciences Business Overview
11.1.3 Gilead Sciences Antiretroviral Drug Introduction
11.1.4 Gilead Sciences Revenue in Antiretroviral Drug Business (2019-2024)
11.1.5 Gilead Sciences Recent Developments
11.2 ViiV Healthcare
11.2.1 ViiV Healthcare Company Details
11.2.2 ViiV Healthcare Business Overview
11.2.3 ViiV Healthcare Antiretroviral Drug Introduction
11.2.4 ViiV Healthcare Revenue in Antiretroviral Drug Business (2019-2024)
11.2.5 ViiV Healthcare Recent Developments
11.3 Bristol-Myer Squibb
11.3.1 Bristol-Myer Squibb Company Details
11.3.2 Bristol-Myer Squibb Business Overview
11.3.3 Bristol-Myer Squibb Antiretroviral Drug Introduction
11.3.4 Bristol-Myer Squibb Revenue in Antiretroviral Drug Business (2019-2024)
11.3.5 Bristol-Myer Squibb Recent Developments
11.4 AbbVie
11.4.1 AbbVie Company Details
11.4.2 AbbVie Business Overview
11.4.3 AbbVie Antiretroviral Drug Introduction
11.4.4 AbbVie Revenue in Antiretroviral Drug Business (2019-2024)
11.4.5 AbbVie Recent Developments
11.5 Boehringer-Ingelheim
11.5.1 Boehringer-Ingelheim Company Details
11.5.2 Boehringer-Ingelheim Business Overview
11.5.3 Boehringer-Ingelheim Antiretroviral Drug Introduction
11.5.4 Boehringer-Ingelheim Revenue in Antiretroviral Drug Business (2019-2024)
11.5.5 Boehringer-Ingelheim Recent Developments
11.6 Johnson and Johnson
11.6.1 Johnson and Johnson Company Details
11.6.2 Johnson and Johnson Business Overview
11.6.3 Johnson and Johnson Antiretroviral Drug Introduction
11.6.4 Johnson and Johnson Revenue in Antiretroviral Drug Business (2019-2024)
11.6.5 Johnson and Johnson Recent Developments
11.7 Merck
11.7.1 Merck Company Details
11.7.2 Merck Business Overview
11.7.3 Merck Antiretroviral Drug Introduction
11.7.4 Merck Revenue in Antiretroviral Drug Business (2019-2024)
11.7.5 Merck Recent Developments
11.8 CIPLA
11.8.1 CIPLA Company Details
11.8.2 CIPLA Business Overview
11.8.3 CIPLA Antiretroviral Drug Introduction
11.8.4 CIPLA Revenue in Antiretroviral Drug Business (2019-2024)
11.8.5 CIPLA Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Gilead Sciences
ViiV Healthcare
Bristol Myer Squibb
AbbVie
Boehringer Ingelheim
Johnson and Johnson
Merck
Cipla Ltd
List of Tables
    Table 1. Global Antiretroviral Drug Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Multi-Class Drugs Combination
    Table 3. Key Players of NRTI
    Table 4. Key Players of NNRTI
    Table 5. Key Players of Protease Inhibitors
    Table 6. Key Players of Other
    Table 7. Global Antiretroviral Drug Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 8. Global Antiretroviral Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 9. Global Antiretroviral Drug Market Size by Region (2019-2024) & (US$ Million)
    Table 10. Global Antiretroviral Drug Market Share by Region (2019-2024)
    Table 11. Global Antiretroviral Drug Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 12. Global Antiretroviral Drug Market Share by Region (2025-2030)
    Table 13. Antiretroviral Drug Market Trends
    Table 14. Antiretroviral Drug Market Drivers
    Table 15. Antiretroviral Drug Market Challenges
    Table 16. Antiretroviral Drug Market Restraints
    Table 17. Global Antiretroviral Drug Revenue by Players (2019-2024) & (US$ Million)
    Table 18. Global Antiretroviral Drug Revenue Share by Players (2019-2024)
    Table 19. Global Top Antiretroviral Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiretroviral Drug as of 2023)
    Table 20. Global Antiretroviral Drug Industry Ranking 2022 VS 2023 VS 2024
    Table 21. Global 5 Largest Players Market Share by Antiretroviral Drug Revenue (CR5 and HHI) & (2019-2024)
    Table 22. Global Key Players of Antiretroviral Drug, Headquarters and Area Served
    Table 23. Global Key Players of Antiretroviral Drug, Product and Application
    Table 24. Global Key Players of Antiretroviral Drug, Product and Application
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Antiretroviral Drug Market Size by Type (2019-2024) & (US$ Million)
    Table 27. Global Antiretroviral Drug Revenue Market Share by Type (2019-2024)
    Table 28. Global Antiretroviral Drug Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 29. Global Antiretroviral Drug Revenue Market Share by Type (2025-2030)
    Table 30. Global Antiretroviral Drug Market Size by Application (2019-2024) & (US$ Million)
    Table 31. Global Antiretroviral Drug Revenue Share by Application (2019-2024)
    Table 32. Global Antiretroviral Drug Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 33. Global Antiretroviral Drug Revenue Share by Application (2025-2030)
    Table 34. North America Antiretroviral Drug Market Size by Type (2019-2024) & (US$ Million)
    Table 35. North America Antiretroviral Drug Market Size by Type (2025-2030) & (US$ Million)
    Table 36. North America Antiretroviral Drug Market Size by Application (2019-2024) & (US$ Million)
    Table 37. North America Antiretroviral Drug Market Size by Application (2025-2030) & (US$ Million)
    Table 38. North America Antiretroviral Drug Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 39. North America Antiretroviral Drug Market Size by Country (2019-2024) & (US$ Million)
    Table 40. North America Antiretroviral Drug Market Size by Country (2025-2030) & (US$ Million)
    Table 41. Europe Antiretroviral Drug Market Size by Type (2019-2024) & (US$ Million)
    Table 42. Europe Antiretroviral Drug Market Size by Type (2025-2030) & (US$ Million)
    Table 43. Europe Antiretroviral Drug Market Size by Application (2019-2024) & (US$ Million)
    Table 44. Europe Antiretroviral Drug Market Size by Application (2025-2030) & (US$ Million)
    Table 45. Europe Antiretroviral Drug Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 46. Europe Antiretroviral Drug Market Size by Country (2019-2024) & (US$ Million)
    Table 47. Europe Antiretroviral Drug Market Size by Country (2025-2030) & (US$ Million)
    Table 48. China Antiretroviral Drug Market Size by Type (2019-2024) & (US$ Million)
    Table 49. China Antiretroviral Drug Market Size by Type (2025-2030) & (US$ Million)
    Table 50. China Antiretroviral Drug Market Size by Application (2019-2024) & (US$ Million)
    Table 51. China Antiretroviral Drug Market Size by Application (2025-2030) & (US$ Million)
    Table 52. Asia Antiretroviral Drug Market Size by Type (2019-2024) & (US$ Million)
    Table 53. Asia Antiretroviral Drug Market Size by Type (2025-2030) & (US$ Million)
    Table 54. Asia Antiretroviral Drug Market Size by Application (2019-2024) & (US$ Million)
    Table 55. Asia Antiretroviral Drug Market Size by Application (2025-2030) & (US$ Million)
    Table 56. Asia Antiretroviral Drug Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 57. Asia Antiretroviral Drug Market Size by Region (2019-2024) & (US$ Million)
    Table 58. Asia Antiretroviral Drug Market Size by Region (2025-2030) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Antiretroviral Drug Market Size by Type (2019-2024) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Antiretroviral Drug Market Size by Type (2025-2030) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Antiretroviral Drug Market Size by Application (2019-2024) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Antiretroviral Drug Market Size by Application (2025-2030) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Antiretroviral Drug Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 64. Middle East, Africa, and Latin America Antiretroviral Drug Market Size by Country (2019-2024) & (US$ Million)
    Table 65. Middle East, Africa, and Latin America Antiretroviral Drug Market Size by Country (2025-2030) & (US$ Million)
    Table 66. Gilead Sciences Company Details
    Table 67. Gilead Sciences Business Overview
    Table 68. Gilead Sciences Antiretroviral Drug Product
    Table 69. Gilead Sciences Revenue in Antiretroviral Drug Business (2019-2024) & (US$ Million)
    Table 70. Gilead Sciences Recent Developments
    Table 71. ViiV Healthcare Company Details
    Table 72. ViiV Healthcare Business Overview
    Table 73. ViiV Healthcare Antiretroviral Drug Product
    Table 74. ViiV Healthcare Revenue in Antiretroviral Drug Business (2019-2024) & (US$ Million)
    Table 75. ViiV Healthcare Recent Developments
    Table 76. Bristol-Myer Squibb Company Details
    Table 77. Bristol-Myer Squibb Business Overview
    Table 78. Bristol-Myer Squibb Antiretroviral Drug Product
    Table 79. Bristol-Myer Squibb Revenue in Antiretroviral Drug Business (2019-2024) & (US$ Million)
    Table 80. Bristol-Myer Squibb Recent Developments
    Table 81. AbbVie Company Details
    Table 82. AbbVie Business Overview
    Table 83. AbbVie Antiretroviral Drug Product
    Table 84. AbbVie Revenue in Antiretroviral Drug Business (2019-2024) & (US$ Million)
    Table 85. AbbVie Recent Developments
    Table 86. Boehringer-Ingelheim Company Details
    Table 87. Boehringer-Ingelheim Business Overview
    Table 88. Boehringer-Ingelheim Antiretroviral Drug Product
    Table 89. Boehringer-Ingelheim Revenue in Antiretroviral Drug Business (2019-2024) & (US$ Million)
    Table 90. Boehringer-Ingelheim Recent Developments
    Table 91. Johnson and Johnson Company Details
    Table 92. Johnson and Johnson Business Overview
    Table 93. Johnson and Johnson Antiretroviral Drug Product
    Table 94. Johnson and Johnson Revenue in Antiretroviral Drug Business (2019-2024) & (US$ Million)
    Table 95. Johnson and Johnson Recent Developments
    Table 96. Merck Company Details
    Table 97. Merck Business Overview
    Table 98. Merck Antiretroviral Drug Product
    Table 99. Merck Revenue in Antiretroviral Drug Business (2019-2024) & (US$ Million)
    Table 100. Merck Recent Developments
    Table 101. CIPLA Company Details
    Table 102. CIPLA Business Overview
    Table 103. CIPLA Antiretroviral Drug Product
    Table 104. CIPLA Revenue in Antiretroviral Drug Business (2019-2024) & (US$ Million)
    Table 105. CIPLA Recent Developments
    Table 106. Research Programs/Design for This Report
    Table 107. Key Data Information from Secondary Sources
    Table 108. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Antiretroviral Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Antiretroviral Drug Market Share by Type: 2023 VS 2030
    Figure 3. Multi-Class Drugs Combination Features
    Figure 4. NRTI Features
    Figure 5. NNRTI Features
    Figure 6. Protease Inhibitors Features
    Figure 7. Other Features
    Figure 8. Global Antiretroviral Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 9. Global Antiretroviral Drug Market Share by Application: 2023 VS 2030
    Figure 10. Hospital Case Studies
    Figure 11. Pharmaceutical Companies Case Studies
    Figure 12. Other Case Studies
    Figure 13. Antiretroviral Drug Report Years Considered
    Figure 14. Global Antiretroviral Drug Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 15. Global Antiretroviral Drug Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 16. Global Antiretroviral Drug Market Share by Region: 2023 VS 2030
    Figure 17. Global Antiretroviral Drug Market Share by Players in 2023
    Figure 18. Global Top Antiretroviral Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiretroviral Drug as of 2023)
    Figure 19. The Top 10 and 5 Players Market Share by Antiretroviral Drug Revenue in 2023
    Figure 20. North America Antiretroviral Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. North America Antiretroviral Drug Market Share by Type (2019-2030)
    Figure 22. North America Antiretroviral Drug Market Share by Application (2019-2030)
    Figure 23. North America Antiretroviral Drug Market Share by Country (2019-2030)
    Figure 24. United States Antiretroviral Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Canada Antiretroviral Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. Europe Antiretroviral Drug Market Size YoY (2019-2030) & (US$ Million)
    Figure 27. Europe Antiretroviral Drug Market Share by Type (2019-2030)
    Figure 28. Europe Antiretroviral Drug Market Share by Application (2019-2030)
    Figure 29. Europe Antiretroviral Drug Market Share by Country (2019-2030)
    Figure 30. Germany Antiretroviral Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. France Antiretroviral Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. U.K. Antiretroviral Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Italy Antiretroviral Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Russia Antiretroviral Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Nordic Countries Antiretroviral Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. China Antiretroviral Drug Market Size YoY (2019-2030) & (US$ Million)
    Figure 37. China Antiretroviral Drug Market Share by Type (2019-2030)
    Figure 38. China Antiretroviral Drug Market Share by Application (2019-2030)
    Figure 39. Asia Antiretroviral Drug Market Size YoY (2019-2030) & (US$ Million)
    Figure 40. Asia Antiretroviral Drug Market Share by Type (2019-2030)
    Figure 41. Asia Antiretroviral Drug Market Share by Application (2019-2030)
    Figure 42. Asia Antiretroviral Drug Market Share by Region (2019-2030)
    Figure 43. Japan Antiretroviral Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. South Korea Antiretroviral Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. China Taiwan Antiretroviral Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Southeast Asia Antiretroviral Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. India Antiretroviral Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Australia Antiretroviral Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 49. Middle East, Africa, and Latin America Antiretroviral Drug Market Size YoY (2019-2030) & (US$ Million)
    Figure 50. Middle East, Africa, and Latin America Antiretroviral Drug Market Share by Type (2019-2030)
    Figure 51. Middle East, Africa, and Latin America Antiretroviral Drug Market Share by Application (2019-2030)
    Figure 52. Middle East, Africa, and Latin America Antiretroviral Drug Market Share by Country (2019-2030)
    Figure 53. Brazil Antiretroviral Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Mexico Antiretroviral Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Turkey Antiretroviral Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Saudi Arabia Antiretroviral Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Israel Antiretroviral Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. GCC Countries Antiretroviral Drug Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 59. Gilead Sciences Revenue Growth Rate in Antiretroviral Drug Business (2019-2024)
    Figure 60. ViiV Healthcare Revenue Growth Rate in Antiretroviral Drug Business (2019-2024)
    Figure 61. Bristol-Myer Squibb Revenue Growth Rate in Antiretroviral Drug Business (2019-2024)
    Figure 62. AbbVie Revenue Growth Rate in Antiretroviral Drug Business (2019-2024)
    Figure 63. Boehringer-Ingelheim Revenue Growth Rate in Antiretroviral Drug Business (2019-2024)
    Figure 64. Johnson and Johnson Revenue Growth Rate in Antiretroviral Drug Business (2019-2024)
    Figure 65. Merck Revenue Growth Rate in Antiretroviral Drug Business (2019-2024)
    Figure 66. CIPLA Revenue Growth Rate in Antiretroviral Drug Business (2019-2024)
    Figure 67. Bottom-up and Top-down Approaches for This Report
    Figure 68. Data Triangulation
    Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Global Tire derived Fuel TDF Market Research Report 2025
Tyre Derived Fuel TDF Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Antiretroviral Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global HIV Antiretroviral Drug Market Research Report 2025
Global Tire Derived Shreds TDS Market Research Report 2025
Global Tire Recycling Downstream Product Market Insights Forecast to 2030
Global Antiviral API Lamivudine TDF and TAF Market Research Report 2024
Global Rheumatic Disorders Drug Market Insights Forecast to 2030
Global Tenofovir Fumarate Market Research Report 2024
Global Antiretroviral Agent Market Research Report 2024
Global Ritonavir Intermediates Market Research Report 2024
Human Immunodeficiency Virus HIV Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Atherosclerosis Drugs Market Insights Forecast to 2030
Global Leishmaniasis Treatment Market Insights Forecast to 2030
Drugs for HIV Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Anti tuberculosis Therapeutics Market Insights Forecast to 2030
Anti HIV Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Metabolic Disorder Therapeutics Market Insights Forecast to 2030
Global TDS Transdermal Delivery Systems Market Insights Forecast to 2030
Global Anti retroviral APIs Market Research Report 2024

RELATED REPORTS

Global Long-Acting HIV-1 Inhibitors Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19B19893
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Methylphenidate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30B3636
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Soliris Intravenous Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3H1702
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Mouth Ulcers Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13C3384
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions